Countries South Korea

LOTTE Biologics Secures First Major Commercial Manufacturing Deal for Songdo Plant 1

Landmark deal validates commercial strategy and reinforces confidence in LOTTE Biologics' advanced manufacturing capabilities Establishes a ...

 November 19, 2026 | News

Thyroscope and TORC to Study Smartphone AI and Orbital Imaging for Thyroid Eye Disease Monitoring

Smartphone monitoring, quantitative orbital imaging and clinical data will support a planned longitudinal study and a TORC-led research database. Thyrosco...

 November 19, 2026 | News

The 10 New Drugs Japan Expects to Sell Most: Peak-Sales Forecasts From Every 2026 NHI Listing Round

On 13 November, 16 new medicines joined Japan's National Health Insurance (NHI) price list. It was the last of the seven listing rounds Japan now runs each...

 November 18, 2026 | Analysis

Heidi Partners With Samsung Medical Center to Adapt Clinical AI for South Korea

Heidi strengthens collaboration with Samsung Medical Center(SMC), South Korea’s premier smart hospital SMC to become Heidi's first partner i...

 November 13, 2026 | News

Roche Expands Asia Pacific Rollout of AXELIOS 1 Sequencing Platform

AXELIOS 1 introduces Roche's proprietary sequencing by expansion (SBX) technology, designed for flexibility and performance to tackle a wide range of seq...

 November 10, 2026 | News

VS Pharmtech Advances Radiotherapy Enhancer VS-101 to Phase 2 in the US

Cancer drugs keep improving, but their limits remain. When antibody therapies first emerged, only a fraction of patients benefited, and small-molecule anti...

 November 09, 2026 | News

Merck Opens €300 Million Bioprocessing Hub in South Korea to Strengthen APAC Supply Chain

Merck’s largest life science investment in Asia-Pacific to date expands regional manufacturing capacity Integrated digital systems suppo...

 October 30, 2026 | News

Yuyu Pharma Champions ‘One Pipeline, Two Markets’ Strategy to Bridge Human and Animal Health

Yuyu Pharma (KRX: 000220) CEO Robert Wonsang Yu shared the company's vision for connecting human and animal health at BIOPLUS-INTERPHEX KOREA 2026 (BIX 202...

 October 30, 2026 | News

17 APAC-Made Biosimilars Approved in the US or EU in 2026

Seventeen times in 2026, the US Food and Drug Administration or the European Commission cleared a biosimilar that was developed or made in Asia-Pacific. Ni...

 October 28, 2026 | Analysis

Orphan Drug Incentives in 9 APAC Markets, Compared

Every January, regulatory affairs teams across Asia-Pacific rebuild the same spreadsheet. Which markets will designate this asset as an orphan? Which will ...

 October 27, 2026 | Analysis

Coreline Soft Secures 13th US FDA Clearance, Expanding AI-Powered CT Imaging into Aortic Assessment

Secures its 13th FDA 510(k) clearance, expanding its U.S. portfolio from lung nodule detection and coronary artery calcium (CAC) analysis to quanti...

 October 26, 2026 | News

Lunit and Summit Therapeutics Join Forces to Decode Tumour Biology with AI-Powered Pathology

Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Bi...

 October 26, 2026 | News

Samsung Biologics Reports KRW 1.49 Trillion Q3 Revenue as Global Manufacturing Expansion Drives Growth

Recorded Q3'26 revenue of KRW 1,490 billion and operating profit of KRW 640 billion Plant 5 ramp-up and U.S. manufacturing operations contribute to earn...

 October 23, 2026 | Company results

What Eight APAC Regulators Have Actually Published on AI in Drug Development

Ask a regulatory affairs lead in Tokyo, Seoul or Singapore what the rules are for using a machine learning model in a drug submission, and the honest answe...

 October 22, 2026 | Analysis


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close